Gilead's remdesivir speeds COVID-19 recovery in US trial
Hospitalised patients with advanced COVID-19 who received remdesivir recovered faster than those given placebo
30th April 2020
Latest news
AZ, Oxford Uni announce 'landmark' COVID-19 vaccine deal
AstraZeneca has taken on development, worldwide manufacturing and distribution of the potential vaccine
30th April 2020
GSK books 19% sales growth for first quarter
Pharmaceutical sales were up 6% on the year ago period
29th April 2020
Bemcentinib first candidate to be tested in unique ACCORD study
ACCORD is a multicentre, seamless, Phase II adaptive randomisation platform trial to assess the efficacy and safety of multiple candidate agents
29th April 2020
New system for capturing COVID-19 death toll in England
The daily UK count will now show the total number of deaths for anyone with a positive test across all settings
29th April 2020
Blueprint's Ayvakit fails to best Bayer's Stivarga
The firm said based on the data it would not be pursuing further development of the drug in GIST beyond its approved indication
29th April 2020
Roche’s risdiplam shows promise in Type 1 SMA
Trial findings are particularly encouraging given that infants already had progressed disease
29th April 2020
National cancer director urges public to get symptoms checked during pandemic
Research shows sharp drop in GP cancer referrals and public concern over seeking medical advice
29th April 2020
AZ delivers strong first quarter
The firm said it remains confident in meeting its 2020 expectations
29th April 2020
ViiV unveils £3m fund to study impact of COVID19 on HIV community
It is hoped that the move will help address some of the questions being asked by the HIV community
28th April 2020
NICE u-turn backs Stelara for UC
Stelara is the first biologic therapy for UC that targets interleukin (IL)-12 and IL-23 cytokines
28th April 2020
Mixed results for Sanofi's Kevzara COVID-19 trial
Kevzara had “no notable benefit” on clinical outcomes when combining the severe and critical groups versus placebo
28th April 2020
EC approves Shionogi's new antibiotic Fetcroja
Fetcroja is the first treatment to provide coverage against all Gram-negative pathogens considered of critical priority
28th April 2020
Novacyt to supply DHSC with COVID-19 tests
Novacyt will supply its COVID-19 test to the DHSC for an initial term of six months
27th April 2020
US clears label update for AZ' Lokelma
The drug's label now includes a dosing regimen specifically to treat hyperkalaemia in patients with end-stage renal disease on stable hemodialysis
27th April 2020
